Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

European Union

Express ferry service for medicines to be introduced as government ramps up no-deal Brexit planning

As the likelihood of a no-deal Brexit increases, the Department of Health and Social Care has outlined further contingency measures. 

The government has announced it will introduce an express freight service for urgent medicines that are in short supply, as part of plans to ramp up preparations for a no-deal Brexit.

The service will apply to “small consignments” of medicines that need to be delivered within 24 to 48 hours and have been given “critical goods” status. They will have priority access to a special cross-channel ferry service, which will be procured by the government.

Preparations to maintain the drugs supply in the event of a no-deal Brexit were put on hold after two Brexit extensions were agreed between the UK government and the EU.

In April 2019, the Department of Health and Social Care (DHSC), wrote to pharmaceutical firms asking them to keep their previously-agreed six-week rolling stockpile of drugs “in place but on hold” until further notice.

However, Boris Johnson and Jeremy Hunt — the final two candidates campaigning to be the UK’s next prime minister — are refusing to rule out a no-deal Brexit, so the government has written to the health and care sector outlining the next steps.

In June 2019, Steve Oldfield, chief commercial officer at the DHSC, wrote to drugs firms and the wider healthcare sector setting out further no-deal Brexit planning and warning that there would be “significant disruption” for six months in the event of the UK leaving the UK with no agreement in place.

“It remains necessary to maintain a multilayered approach to contingency, in order to secure continuity of supply for medicines and medical products, ahead of a potential 31 October 2019 no-deal [Brexit],” the letter said.

While the express service and priority status given to medicines was welcomed by the pharmaceutical industry and others, there was still concern over whether the supply chain will remain intact if there is no deal.

Ash Soni, president of the Royal Pharmaceutical Society, welcomed the priority given to medicines but expressed concern about the effect of patients creating their own medicines stockpiles, combined with existing medicines shortages.

“From a pharmacist’s perspective, I am also worried that sometime in the next three months the government will ask contractors to increase their medicine stocks. If somebody were to ask me to do that I have no idea how I could afford it,” he added.

Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, said: “It is extremely challenging for pharmaceutical companies to be continually preparing for a no-deal Brexit. Leaving the EU with a deal in place remains the best way to minimise any potential disruption to medicines supplies.”

Meanwhile, Niall Dickson, chief executive of the NHS Confederation, said: “The truth is that much of this is outside of the control of the NHS and our members; that is why we continue to advocate a negotiated deal which will provide maximum protection for patients.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206733

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.